Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: A post hoc analysis

Journal of Clinical Psychiatry

Volumn 70, Issue 10, 2009, Pages 1424-1431

  Benazzi, Franco ^a,b,c,d   Berk, Michael ^e,f,g,h   Frye, Mark A ⁱ   Wang, Wei ^j   Barraco, Alessandra ^k   Tohen, Mauricio ^l  

^a Hecker Psychiatry Research Center   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SZEGED   (Hungary)

^d DEPARTMENT OF PSYCHIATRY   (Italy)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f ORYGEN RESEARCH CENTRE   (Australia)

^g BARWON HEALTH   (Australia)

^h FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

ⁱ Mayo Clinic   (United States)

^j ELI LILLY AND COMPANY   (United States)

^k Ely Lilly Italy   (Italy)

^l UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE PLUS OLANZAPINE; OLANZAPINE;

ADULT; ARTICLE; BIPOLAR I DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; MANIA; MIXED MANIA AND DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; YOUNG MANIA RATING SCALE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FEMALE; FLUOXETINE; HUMANS; MALE; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISPERIDONE; TREATMENT OUTCOME;

EID: 72249116768     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.08m04772gre     Document Type: Article

References (50)

1. Goodwin FK, Jamison KR. Manic-Depressive Illness. 2nd ed. Oxford, England: Oxford University Press; 2007.
2. Marneros A. Origin and development of concepts of bipolar mixed states. J Affect Disord. 2001;67(1-3):229-240. PubMed doi:10.1016/S0165-0327(01)00437-2 (Pubitemid 34183355)
3. Kraepelin E. Manic-Depressive Insanity and Paranoia. Edinburgh, Scotland: Livingstone E & S; 1921.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
5. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva, Switzerland: World Health Organization; 1992.
6. Tohen M, Waternaux CM, Tsuang MT. Outcome in mania: a 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry. 1990;47(12):1106-1111. PubMed
7. McElroy SL, Keck PE Jr, Pope HG Jr, et al. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry. 1992;149(12):1633-1644. PubMed
8. Cassidy F, Yathan LN, Berk M, et al. Pure and mixed manic subtypes: a review of diagnostic classification and validation. Bipolar Disord. 2008;10(1, pt 2):131-143. PubMed
9. Benazzi F. Bipolar disorder-focus on bipolar II disorder and mixed depression. Lancet. 2007;369(9565):935-945. PubMed doi:10.1016/S0140-6736(07) 60453-X (Pubitemid 46400860)
10. Benazzi F. Reviewing the diagnostic validity and utility of mixed depression (depressive mixed states). Eur Psychiatry. 2008;23(1):40-48. PubMed doi:10.1016/j.eurpsy.2007.07.003 (Pubitemid 351221251)
11. Bauer MS, Simon GE, Ludman E, et al. "Bipolarity" in bipolar disorder: distribution of manic and depressive symptoms in a treated population. Br J Psychiatry. 2005;187:87-88. PubMed doi:10.1192/bjp.187.1.87
12. Suppes T, McElroy SL, Altshuler LL, et al. Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Bipolar Treatment Network: a gender-specific phenomenon. Arch Gen Psychiatry. 2005;62(10):1089-1096. PubMed doi:10.1001/archpsyc.62.10.1089 (Pubitemid 41396934)
13. Goldberg JF, Perlis RH, Bowden CL, et al. Mania symptoms during depressive episodes in 1380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry. 2009;166(2):173-181. PubMed doi:10.1176/appi.ajp.2008. 08050746
14. Frye MA, Helleman G, McElroy SL, et al. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry. 2009;166(2):164-172. PubMed doi:10.1176/appi.ajp.2008.08030322
15. Koukopoulos A, Albert MJ, Sani G, et al. Mixed depressive states: nosologic and therapeutic issues. Int Rev Psychiatry. 2005;17(1):21-37. PubMed doi:10.1080/09540260500064744 (Pubitemid 40591404)
16. Sato T, Bottlender R, Kleindienst N, et al. Irritable psychomotor elation in depressed inpatients: a factor validation of mixed depression. J Affect Disord. 2005;84(2-3):187-196. PubMed doi:10.1016/S0165-0327(02)00172-6 (Pubitemid 40222500)
17. Maj M, Pirozzi R, Magliano L, et al. Agitated depression in bipolar I disorder: prevalence, phenomenology, and outcome. Am J Psychiatry. 2003;160(12):2134-2140. PubMed doi:10.1176/appi.ajp.160.12.2134 (Pubitemid 39619606)
18. Maj M, Pirozzi R, Magliano L, et al. Agitated "unipolar" major depression: prevalence, phenomenology, and outcome. J Clin Psychiatry. 2006;67(5):712-719. PubMed (Pubitemid 43946177)
19. Akiskal HS, Benazzi F. Family history validation of the bipolar nature of depressive mixed states. J Affect Disord. 2003;73(1-2):113-122. PubMed doi:10.1016/S0165-0327(02)00330-0 (Pubitemid 36044639)
20. Akiskal HS, Benazzi F, Perugi G, et al. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J Affect Disord. 2005;85(3):245-258. PubMed doi:10.1016/j.jad.2004.12.004 (Pubitemid 40386508)
21. Swann AC, Gerard Moeller F, Steinberg JL, et al. Manic symptoms and impulsivity during bipolar depressive episodes. Bipolar Disord. 2007;9(3):206-212. PubMed doi:10.1111/j.1399-5618.2007.00357.x
22. Biondi M, Picardi A, Pasquini M, et al. Dimensional psychopathology of depression: detection of an "activation" dimension in unipolar depressed outpatients. J Affect Disord. 2005;84(2-3):133-139. PubMed doi:10.1016/S0165-0327(02)00103-9
23. Benazzi F. Defining mixed depression. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(4):932-939. PubMed doi:10.1016/j.pnpbp.2007.12.019
24. Benazzi F. A tetrachoric factor analysis validation of mixed depression. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(1):186-192. PubMed doi:10.1016/j.pnpbp.2007.08.005
25. Berk M, Malhi GS, Cahill AC, et al. The Bipolar Depression Rating Scale (BDRS): its development, validation and utility. Bipolar Disord. 2007;9(6):571-579. PubMed doi:10.1111/j.1399-5618.2007.00536.x (Pubitemid 47365624)
26. US Food and Drug Administration. Revisions to Product Labeling. http://www.fda.gov/cder/drug/antidepressants/antidepressants-label-change-2007. Accessed March 3, 2008.
27. Akiskal HS. The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. J Clin Psychopharmacol. 1996;16(2):4S-14S. PubMed doi:10.1097/00004714- 199604001-00002
28. Bottlender R, Sato T, Kleindienst N, et al. Mixed depressive features predict maniform switch during treatment of depression in bipolar I disorder. J Affect Disord. 2004;78(2):149-152. PubMed doi:10.1016/S0165-0327(02)00265-3 (Pubitemid 38045474)
29. Goldberg JF, Perlis RH, Ghaemi SN, et al. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry. 2007;164(9):1348-1355. PubMed doi:10.1176/appi.ajp.2007.05122032
30. Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. 2003;60(11):1079-1088. PubMed doi:10.1001/archpsyc.60.11.1079 (Pubitemid 37429647)
31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
32. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389. PubMed doi:10.1192/bjp.134.4.382 (Pubitemid 9136500)
33. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Version (SCID). Washington, DC: American Psychiatric Press; 1997.
34. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry. 1978;133:429-435. PubMed doi:10.1192/bjp.133.5.429
35. Sato T, Bottlender R, Schroter A, et al. Frequency of manic symptoms during a depressive episode and unipolar "depressive mixed state" as bipolar spectrum. Acta Psychiatr Scand. 2003;107(4):268-274. PubMed doi:10.1034/j.1600-0447.2003.00051.x
36. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976.
37. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905-1917. PubMed doi:10.1176/appi.ajp.163.11.1905
38. Rihmer Z, Gonda X. Is drug-placebo difference in short-term antidepressant drug trials on unipolar major depression much greater than previously believed? J Affect Disord. 2008;108(3):195-198. PubMed doi:10.1016/j.jad.2008.01.020
39. Berk M, Dodds S, Malhi GS. "Bipolar missed states": the diagnosis and clinical salience of bipolar mixed states. Aust N Z J Psychiatry. 2005;39(4):215-221. PubMed doi:10.1111/j.1440-1614.2004.01557.x (Pubitemid 40601658)
40. Bowden CL, Singh V, Thompson P, et al. Development of the Bipolar Inventory of Symptoms Scale. Acta Psychiatr Scand. 2007;116(3):189-194. PubMed doi:10.1111/j.1600-0447.2006.00955.x
41. Benazzi F. Depressive mixed state: dimensional versus categorical definitions. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(1):129-134. PubMed doi:10.1016/S0278-5846(02)00343-3 (Pubitemid 36126654)
42. Ghaemi SN. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression. Bipolar Disord. 2008;10(8):957-968. doi:10.1111/j.1399-5618.2008.00639.x
43. Goldberg JF. The modern pharmacopeia: a return to depressive realism? Bipolar Disord. 2008;10(8):969-972. doi:10.1111/j.1399-5618.2008.00632.x
44. Cassidy F. Antidepressants treatment practice in the face of STAR*D and STEP-BD. Bipolar Disord. 2008;10(8):973-974. doi:10.1111/j.1399-5618.2008. 00631.x
45. Benazzi F. Bipolar II disorder: epidemiology, diagnosis and management. CNS Drugs. 2007;21(9):727-740. PubMed doi:10.2165/00023210-200721090-00003 (Pubitemid 47294719)
46. Malhi GS. Upping the ante on antidepressants. Bipolar Disord. 2008;10(8)975-978. doi:10.1111/j.1399-5618.2008.00645.x
47. Benazzi F. The problem of the treatment of bipolar-II depression. Bipolar Disord. 2004;6(5):440-441. PubMed doi:10.1111/j.1399-5618.2004.00125.x
48. Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med. 1992;116(1):78-84. PubMed
49. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology, 3rd edition. Philadelphia, PA: Wolters Kluwer / Lippincott Williams & Wilkins; 2008
50. Rothman KJ. Epidemiology. An Introduction. Oxford, England: Oxford University Press; 2002:126.